1,002
Participants
Start Date
February 6, 2017
Primary Completion Date
September 21, 2017
Study Completion Date
March 12, 2018
IPV-Al SSI
3 primary injections of IPV-Al SSI at 6, 10, and 14 weeks of age and 1 booster at 9 months of age
IPV SSI
3 primary injections of IPV SSI at 6, 10, and 14 weeks of age and 1 booster at 9 months of age
5 sites in Philippines, Manila
Collaborators (2)
Bill and Melinda Gates Foundation
OTHER
Larix A/S
INDUSTRY
Syneos Health
OTHER
AJ Vaccines A/S
INDUSTRY
Statens Serum Institut
OTHER